Disease-A-Month
Volume 56, Issue 3 , Pages 106-147 , March 2010

Hypertension and Cognitive Function in the Elderly

  • Antonio Cherubini, MD, PhD

      Affiliations

    • Gerontology and Geriatrics, University of Perugia, Perugia, Italy
    • ,
  • David T. Lowenthal, MD, PhD

      Affiliations

    • Veterans Affairs Medical Center, University of Florida, Gainesville, Florida
    • ,
  • Esther Paran, MD

      Affiliations

    • Department of Medicine Hypertension Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
    • ,
  • Patrizia Mecocci, MD, PhD

      Affiliations

    • Veterans Affairs Medical Center, University of South Florida, Tampa, Florida
    • ,
  • Leonard S. Williams, MD

      Affiliations

    • Veterans Affairs Medical Center, University of South Florida, Tampa, Florida
    • ,
  • Umberto Senin, MD

      Affiliations

    • Gerontology and Geriatrics, University of Perugia, Perugia, Italy

References 

  1. Lowenthal DT, Powers S, Pollock ML, et al. Interactions of Blockage and Exercise: Implications and Applications for the Elderly. Am J Geriatr Cardiol. 1992;1:42–57
  2. Vogt TM, Ireland CC, Black D, et al. Recruitment of elderly volunteer for multi-center clinical trial: The SHEP pilot study. Controlled Clin Trials. 1986;7:118
  3. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: The Framingham study. Bull NY Acad Med. 1978;54:573
  4. O'Connor DW, Pollitt PA, Ilyde JB, et al. The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand. 1989;79:190–198
  5. Ueda K, Kawano H, Hasuo Y, et al. Prevalence and etiology of dementia in a Japanese community. Stroke. 1992;23:798–802
  6. Zhang M, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shangai, China: impact of age, gender, and education. Ann Neurol. 1990;27:428–437
  7. Rocca WA, Bonaiuto S, Lippi A, et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door to door study in Appingnano, Macerata Province, Italy. Neurology. 1990;40:626–631
  8. Barclay LL. Survival in Alzheimer's disease and vascular dementias. Neurology. 1985;35:834
  9. Molsa PK, Martilla RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and vascular dementia. Acta Neurol Scand. 1986;74:103–107
  10. Skoog I, Nilsson L, Palmertz B, et al. A population based study of dementia in 85-years olds. N Engl J Med. 1993;153–158
  11. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology. 1995;45:1161–1168
  12. Lindsay J, Ilébert R, Rockwood K. The Canadian Study of Health and Aging: Risk factors for vascular dementia. Stroke. 1997;48:526–530
  13. Skoog I. Risk factors for vascular dementia. Dementia. 1994;5:137
  14. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology. 1998;17:2–9
  15. Saunders AM, Strillmatter WJ, Schmechel D. Association of Apolipoprotein E 4 allele with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467–1472
  16. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E 4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240–242
  17. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation. 1976;53:720–727
  18. Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet. 1994;344:519–524
  19. Goodwin JS. Embracing Complexity: A consideration of hypertension in the very old. J Gerontol A Biol Sci Med Sci. 2003;58:653–658
  20. Lowenthal DT. Commentary on “Embracing complexity: A Consideration of Hypertension in the Very Old”. J Gerontol A Biol Sci Med Sci. 2003;58:664–665discussion 669-70
  21. Vincent KR, Vincent HK, Braith RW, et al. Strength Training and Hemodynamic Responses to Exercise. Lowenthal, Am J Geriatr Cardiol. 2003;12:97–106
  22. Larson EB, Kukull WA, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107:169–173
  23. Prince MJ. The treatment of hypertension is in older people and its effect on cognitive function. Biomed Pharmacother. 1997;51:208–212
  24. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control. Stroke. 1996;27:2262–2270
  25. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041
  26. The PROGRESS Collaborative Group. Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients with Cerebrovasular Disease. Arch Intern Med. 2003;163:1069–1075
  27. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  28. Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning (The Framingham Study). Am J Epidemiol. 1993;138:353–364
  29. Waldstein SR, Manuck SB, Ryan CM, et al. Neuropsychological correlates of hypertension: review and methodological considerations. Psychol Bull. 1991;110:451–468
  30. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E_4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240–242
  31. Applegate WB, Pressel S, Wittes J, et al. Impact in the treatment of isolated systolic hypertension of behavioral variables (Results from the systolic hypertension in the elderly program). Arch Intern Med. 1994;154:2154–2160
  32. Soloman S, Hotchkiss E, Saravay SM, et al. Impairment of memory function by antihypertensive medication. Arch Gen Psychiatry. 1983;40:1109–1112
  33. van Swieten JC, Geyskes GG, Derrix MMA, et al. Hypertension in the elderly is associated with white matter lesions and congitive decline. Ann Neurol. 1991;30:825–830
  34. Burke DM, Harrold RM. Automatic effortful semantic processes in old age: experimental and naturalistic approaches. In:  Light LL,  Burke DM editor. Language, Memory and Aging. New York: Cambridge University Press; 1988;p. 100–116
  35. Glynn RJ, Beckett LA, Hebert LE, et al. Current and remote blood pressure and cognitive decline. JAMA. 1999;281:438–445
  36. Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of ß-blockers. Arch Intern Med. 1989;149:514–525
  37. Elias MF, Robbins MA, Shultz NR, et al. Clinical significance of cognitive performance by hypertensive patients. Hypertension. 1987;9:192–197
  38. Lindsay J, Hébert R, Rockwood K. The Canadian Study of Health and Aging: Risk factors for vascular dementia. Stroke. 1997;48:526–530
  39. Applegate WB, Phillips HL, Schnaper H, et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med. 1991;151:1817–1823
  40. Taylor JO, Cornioni-Huntley J, Curb JD, et al. Blood pressure and mortality risk in the elderly. Am J Epidemiol. 1991;134:489
  41. Scherr PA, Hebert LE, Smith LA, et al. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol. 1991;134:1303–1315
  42. Wallace R, Blemke JH, Morris MC, et al. Relationship of free recall memory to hypertension in the elderly (The Iowa 65+ rural health study). J Chron Dis. 1985;38:475–481
  43. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641–1647
  44. Schlotterer G, Moscovitch M, Crapper M, et al. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal aging and Alzheimer's disease. Brain. 1984;107:309–325
  45. Vaitkevicius PV, Fleg JL, Engl JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456–1462
  46. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25:155–161
  47. Cruikshank JM, Thorp JM, Zacharis FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;i:581–584
  48. Roman GC, Tatemichi TK, Erkinijutti T, et al. Vascular dementia: diagnostic criteria for research studies (Report of the NINDSD-AIREN International Workshop). Neurology. 1993;43:250–260
  49. Fletcher AE, Bulpitt CJ. How far should blood pressure be lowered?. N Eng J Med. 1992;326:251–254
  50. Zwetnow NN. Pathophysiology of autoregulation. In:  Minderhoud JM editors. Cerebral Blood Flow: Basic Knowledge and Clinical Implications. Amsterdam: Excerpta Medica; 1981;
  51. Zhang M, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shangai, China: impact of age, gender, and education. Ann Neurol. 1990;27:428–437
  52. Kwok RPS, Juorio AW. Facilitating effect of insulin on brain 5-hydroxytriptamine metabolism. Neuroendocrinology 197;45:267-73.
  53. Canestrari RE. The effects of commonality on paired-associated learning in two age groups. J Genetic Psychol. 1996;108:3–7
  54. Hardy J, Adolfsen R, Alafuzoff I, et al. Transmitter deficits in Alzheimer's disease. Neurochem Int. 1985;7:545–563
  55. Hong YL. The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. Int J Clin Pharmacol Ther Toxicol. 1987;11:589–597
  56. Starr JM, Whalley IJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc. 1996;44:411–415
  57. Overgaard JM. Cerebral blood flow and severe head injury. In:  Minderhoud JM editors. Cerebral Blood Flow: Basic Knowledge and Clinical Implications. Amsterdam: Excerpta Medica; 1981;
  58. Skoog I. The relationship between blood pressure and dementia: a review. Biomed & Pharmacother. 1997;51:367–375
  59. Erkinjuntti T, Ketonen L, Sulkava R, et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?. J Neurol Neurosurg Psychiatry. 1987;50:37–42
  60. Erkinjuntti T, Ostbye T, Steenhuis R, et al. The effects of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667–1674
  61. Skoog I, Nilsso L, Palmertz B, et al. A population based study of dementia in 85-year-olds. N Eng J Med. 1993;328:153–158
  62. Blum JE, Javich LF, Clark ET. Rate of change on selective tests of intelligence: a twenty-five longitudinal study of aging. J Gerontol. 1970;25:171–176
  63. Rocca WA, Bonaiuto S, Lippi A, et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door to door study in Appignano, Maccerata Province, Italy. Neurology. 1990;40:626–631
  64. Roman GC, Tatemichi TK, Erkinijutti T, et al. Vascular dementia: diagnostic criteria for research studies (Report of the NINDSD-AIREN International Workshop). Neurology. 1993;43:250–260
  65. Celesia GC, Daly RF. Effects of aging on visual evoked responses. Arch Neurol. 1977;34:403–407
  66. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral hemorrhage. Lancet. 1995;346:575;(letter)
  67. Applegate WB, Pressel S, Eittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables (Results from the systolic hypertension in the elderly program). Arch Intern Med. 1994;154:2154–2160
  68. Maxwell CJ, Hogan DB, Ebly EM. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ. 1991;161:501–506
  69. Seux MI, Thijs L, Forette F, et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens. 1998;16:963–969
  70. Zhu L, Viitanen M, Guo Z, et al. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three year follow-up. J Clin Epidemiol. 1998;51:385–391
  71. Birns J, Kalra L. Blood pressure and vascular cognitive impairment: the debate continues. J Hum Hypertens. 2006;20:1–3
  72. Launer LJ, Masaki K, Petroviecb H, et al. The association between mid-life blood pressure levels and late-life cognitive function: The Honolulu-Asia aging study. JAMA. 1995;274:1846–1851
  73. Feigin V, Ratnasabapathy Y, Andersn C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?. J Neurol Sci. 2005;229(-230):151–155
  74. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP) (SHEP Cooperative Research Group). JAMA. 1991;265:3255–3264
  75. Prince MJ, Bird AS, Blizard RA, et al. Is the cognitive function of older patients affected by antihypertensive treatment? (Results from 54 months of the Medical Research Council's trial of hypertension in older adults). BMJ. 1996;312:801–805
  76. Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens. 2004;22:1605–1612
  77. Forette I, Seux ML, Staessen JA, et al. Prevention of dementia in randomized, double-blind, placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  78. Feldmann E. Intracerebral hemorrhage. Stroke. 1991;22:684-491
  79. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc. 1996;44:411–415
  80. Starr JM, Whalley LJ. Differential cognitive outcomes in the hypertensive old people in Edinburgh study. J Neurol Sci. 2005;229(-230):103–107
  81. Alagiakrishnan K, McCracken P, Feldman H. Treatment vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline?. Postgrad Med J. 2006;82:101–105
  82. Guo Z, Vitanen M, Fratiglioni L, et al. Low blood pressure and dementia in elderly people: the Kungshol-men project. Br Med J. 1996;312:805–808
  83. Lindgren A, Roijer A, Rudling O, et al. Cerebral lesion on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke. 1994;25:929–934
  84. Brust JC. Antihypertensive therapy and cognition: more questions than answers. Stroke. 2006;37:1146
  85. Faston JD, Albers GW, Caplan LR, et al. Discussion: reconsideration of TIA terminology and definitions. Neurology. 2004;62:529–534
  86. Phillips SJ, Whisnant JP. Hypertension and stroke. In:  Laragh JH,  Brenner BM editor. Hypertension: pathophysiology, diagnosis and management. New York, NY: Raven Press; 1990;p. 417–431
  87. Strandgaard S, Paulson OB. Cerebrovascular consequence of hypertension. Lancet. 1994;344:519–524
  88. Granick S. Psychological test functioning. In:  Granick S,  Patterson RD editor. Human Aging II: US Department of Health, Education and Iluman Welfare. Rockville, MD: DHEW Publication (HSM); 1971;p. 70–90
  89. Sparks DL, Scheff SW, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 1995;131:162–168
  90. Waldstein SR, Ryan CM, Manuck SB, et al. Learning and memory function in men with untreated blood pressure elevation. J Consult Clin Psychol. 1991;79:513–517
  91. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke. 1995;26:1593–1597
  92. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J. 1994;150:899–913
  93. Barbeger-Gateau P, Fabrigaule C. Disability and Cognitive Impairment in the Elderly. Disabil Rehabil. 1997;19:175–193
  94. Stoog I, Nilsso L, Palmertz B, et al. A population based study of demential in 85-year-olds. N Eng J Med. 1993;328:153–158
  95. Kinkel WR, Jacobs L, Palochini I, et al. Subcortical arteriosclerotic encephalopathy (Binswanger's disease): computed tomography, nuclear magnetic resonance and clinical correlations. Arch Neurol. 1985;52:659–664
  96. Feldmann E. Intracerebral hemorrhage. Stroke. 1991;22(684):491
  97. Senin U. The aging brain. Perugia: Editriec Sigla Trc; 1983;
  98. Senin U, Parnetti I, Mecocci P. The aging demented brain and calcium antagonists. Intramed communications; 1994;
  99. Senin U, Aisa G, Catani M, et al. Aging patient and geriatric fundamentals of geronotology and geriatrics. EdiScs; 1999;
  100. Skinner H, Futerman A, Morrissette D, et al. Atenolol compared with infedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med. 1992;116:615–623
  101. Suzman RM, Willis DP, Manton KG. The oldest old. Oxford University press; 1992;
  102. Ingvar DH, Lassen NA. Regulation of cerebral blood flow. In:  Himwich HE editors. Brain Metabolism and Cerebral Disorders. 2nd Ed.. New York: Spectrum Publications; 1976;p. 181;Ch 8
  103. van Boxtel MP, Gaillard C, Houx PJ, et al. Can the blood pressure predict cognitive task performance in a healthy population sample?. J Hypertens. 1997;15:1069–1076
  104. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for endpoint reduction in hypertension study (LIFT): a randomised trial against atenolol. Lancet. 2002;359:995–1003
  105. Paran E, Horaf RA, Hanson A, et al. Blood pressure and cognitive functioning among independent elderly. Am J Hypertens. 2003;16:818–826
  106. PROGRESS Collaborative Group. Randomised trial of a perindepril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041
  107. Brun A, Englund B, Gustafason L. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiat. 1994;57:417–418
  108. Meyer JS. Improved method for non-invasive measurement of regional cerebral blood flow by 133 Xenon inhalation, Part II: measurements in health and disease. Stroke. 1978;9:205
  109. Acherio A, Hennekens C, Willett C, et al. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension. 1996;27:1065–1072
  110. Kral VA. Senescent forgetfulness: benign or malignant. Can Med Assoc J. 1962;86:257–260
  111. Krakof LR. Renal and adrenal mechanism pertinent to hypertension in an aging population. In:  Horan MJ,  Steinberg GM,  Dunbar JAB, et al. editor. Blood Pressure Regulation and Aging. New York: Biomedical Information Corp; 1986;
  112. Zijlstra WG. Physiology of the cerebral circulation. In:  Minderhoud JM editors. Cerebral Blood Flow: Basic Knowledge and Clinical Implications. Amsterdam: Excerpta Medica; 1981;
  113. Mrak RE, Griffin WST, Graham DL. Aging-associated changes in human brain. J Neuropathol Exp Neurol. 1997;56:1269–1275
  114. Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group. Dev Neuropsychol. 1986;4:261–276
  115. Bierman EI. Aging and atherosclerosis. In:  Hazzard WR,  Bierman EL,  Blass JP, et al. editor. Principles of Geriatric Medicine and Gerontology. 3rd Ed.. New York: McGraw-Hill; 1994;
  116. Hendrie HC. Epidemiology of Dementia and Alzheimer's Disease. Am J Geriatr Psychiatry. 1998;6(2 Suppl 1):S3–S18
  117. Applegate WB, Pressel S, Wittes J, et al. Impact in the treatment of isolated systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154–2160
  118. Craik FIM. Two components in free recall. J Verbal Learn Verbar Behav. 1968;7:996–1004
  119. Birren JE, Fisher M. Aging and speed of behavior: possible consequences for psychological functioning. Ann Rev Psychol. 1995;46:329–353
  120. Hazzard WR. The scx differential in longevity. In:  Hazzard WR,  Bierman EL,  Blass JP, et al. editor. Principles of Geriatric Medicine and Gerontology. 3rd Ed.. New York: McGraw-Hill; 1994;p. 37–47
  121. Krakof LR. Renal and adrenal mechanism pertinent to hypertension in an aging population. In:  Horan MJ,  Steinberg GM,  Dunber JAB, et al. editor. Blood Pressure Regulation and Aging. New York: Biomedical Information Corp; 1986;
  122. Gill TM, Richardson FT, Tinetti ME. Evaluating the risk of dependence in activities of daily living among community living older adults with mild to moderate cognitive impairment. J Gerontol. 1995;5:M235–M241
  123. Chobanian AV. Pathophysiologic considerations in the treatment of the elderly hypertension patient. Am J Cardiol. 1983;52:49D
  124. Abrass IB. Vatecholamine levels and vascular responsiveness in aging. In:  Horan MJ,  Steinberg GM,  Dunber JB, et al. editor. Blood Pressure Regulation and Aging. New York: Biomedical Information Corp; 1986;
  125. Folstein M, Folstein S, McHugh P. Mini Mental State: a practical method for grading the cognitive state of patients for a clinician. J Psychiatr Res. 1975;12:189–198
  126. Forette F, Scux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  127. Lipowsky ZJ. Delirum: Acute confusinal States. New York: Oxford University Press; 1990;
  128. Craik FIM. Short-term memory and the aging process. In:  Talland GA editors. Human Aging and Behavior. New York: Academic Press; 1968;p. 131–168
  129. Stuart-Hamilton I. The psychology of aging, an introduction. London: Jessica Kingsley Publisher; 1991;
  130. Burke WJ, Coronado PG, Schmitt CA, et al. Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst. 1994;48:65–71
  131. Skoog I. Risk Factors for vascular dementia. Dementia. 1994;5:137
  132. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959–962
  133. Cattel RB. Abilities: their structure, growth and action. Boston: Houghton-Mifflin; 1971;
  134. Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet. 1994;344:519–524
  135. Chimovitz MI, Awad IA, Furlan AJ. Periventricular lesions on MRI (Facts and theories). Stroke. 1989;20:963–967
  136. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease, Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774
  137. Erkinjuntti T, Gao F, Lee DH, et al. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol. 1994;51:1084–1089
  138. Linee guida 1999 per il trattamento dell'organizzazione mondiale della Sanita‵ (OMS) c della Secieta‵ Internazio-nale dell'Ipertensione (ISH). J Hypertens. 1999;17:151–183
  139. Skoog I, Lernfelt B, Landahal S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141–1145
  140. Hatazawa J, Yamaguchi T, Ito M, et al. Association of hypertension with increased atrophy of brain matter in the elderly. J Am Geriatr Soc. 1984;32:370–371
  141. Campion EW. The oldest old. N Engl J Med. 1994;330:1819–1820
  142. Ileckbert SR, Longsteth WT, Psaty BM, et al. The association of antihypertensive examination in older adults. J Am Geriatr Soc. 1997;45:1423–1433
  143. Schwartz M, Creascy H, Grady CL, et al. Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21 to 81 years. Ann Neurol. 1985;17:146–157
  144. Aronson MK, Post DC, Guastadisegni P, et al. Weight changes and dementia. In:  Corain B,  lqbal K,  Nicolini M, et al. editor. Alzheimer's Disease: Advances in Clinical and Basic Research. New York: Jolut Wiley and Sons; 1993;p. 55–63
  145. Wylie CM. Contrast in the health of elderly men and women: an analysis of recent data for Whites in the United States. J Am Geriatr Soc. 1984;38:670–675
  146. Salcrno JA, Murphy DGM, Horwitz B, et al. Brain atrophy in hypertension (A volumetric magnetic resonance imaging study). Hypertension. 1992;20:340–348
  147. Albert M, Smith LA, Scherr PA, et al. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci. 1991;31:167–178
  148. Moody DL, Bell MA, Challa VR. Regional cerebral vulnerability to perfusion deficits in the elderly. New Issues Neurosci. 1992;4:133–145
  149. Launer LJ, Anersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses (FURODEM Incidence Research Group and Work Groups. European Studies of Dementia). Neurology. 1999;52:78–84
  150. Skoog I, Nilsso L, Palmertz B, et al. A population based study of dementia in 85-year-olds. N Eng J Med. 1993;328:153–158
  151. Havlik RJ. Antihypertensive drugs, brain structure and cognitive function: more research is necessary. J Am Geriatr Soc. 1997;45:1529–1531
  152. Cohen ML, Berkowitz BA. Vascular contraction: effective age and extracellular calcium. Res Commun Chem Pathol Pharmacol. 1979;26:433
  153. Langer DR, Ganiats TG, Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. Br Med J. 1989;298:1356–1358
  154. Meyer JS, Judd BW, Tawaklna T, et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA. 1986;256:2203–2209
  155. Roman GC. From UBOs to Binswanger's disease (Impact of magnetic resonance imaging on vascular dementia research). Stroke. 1996;27:1269–1273
  156. Mann SJ. Systolic hypertension in the elderly. Arch Intern Med. 1992;152:1977–1984
  157. Bryan P, Efong DO, Steward-Jones J, et al. Propranolol on tests of visual function and central nervous system activity. Br J Clin Pharmacol. 1974;1:82–84
  158. Roman GC. Form UBOs to Binswanger's discase (Impact of magnetic resonance imaging on vascular dementia research). Stroke. 1996;27:1269–1273
  159. Pantoni I, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger' disease. Stroke. 1995;26:1293–1301
  160. Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesion identified on magnetic resonance imaging in the elderly (I: correlation with the age and cerebrovascular risk factors). Stroke. 1986;17:1084–1089
  161. Lopez OL, Beeker JT, Jungreis CA, et al. Computed tomography, but not magnetic resonance imaging-identified periventricular white matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol. 1995;52:659–664
  162. Farmer ME, Withe LR, Abbot RD, et al. Blood pressure and cognitive performance: The Framingham study. Am J Epidemiol. 1987;126:1103–1114
  163. Bryan P, Efong DO, Steward-Jones J, et al. Propranolol on tests of visual function and central nervous system activity. Br J Clin Pharmacol. 1974;1:82–84
  164. Schmidt R, Fazekas F, Koch M, et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects: a case-control study. Arch Neurol. 1995;52:856–910
  165. Longstreth WT, Manolio TA, Arnold A, et al. cardiovascular health study group Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people (The Cardiovascular Health Study). Stroke. 1996;27:1274–1282
  166. Hallock P, Benson IC. Studies of the elastic properties of human isolated aorta. J Clin Invest. 1937;16:595
  167. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th Ed.. Washington, DE: American Psychiatric Association; 1994;
  168. Sixth report of the Joint National Committee on Prevention, Detection (Evaluation and Treatment of High Blood Pressure). Arch Intern Med. 1997;157:2413–2445
  169. Roman GC. From UBOs to Binxwanger's disease (Impact of magnetic resonance imaging on vascular dementia research). Stroke. 1996;27:1269–1273
  170. Salvioli G, Mussi C, Ascari S. Il Deliruim nell' Anziano. Giorn Geront. 1998;46:423–432
  171. Kuusisto J, Koivisto K, Mykkanen L, et al. Essential hypertension and cognitive function (The role of hyperinsulinemia). Hypertension. 1993;22:771–779
  172. Phillips SJ, Whisnant JP. Hypertension and stroke. In:  Laragh JH,  Brenner BM editor. Hypertension, Pathophysiology, Diagnosis and Management. New York: Raven Press; 1990;417-31
  173. Gist YJ, Velkoff VA. Gender and aging. Demographic dimensions. International brief. Bureau of Census. US Department of Commerce, Economics and Statistics Administration; 1997;
  174. Lopez OL, Becker JT, Jungreis CA, et al. Computed tomography, but not magnetic resonance imaging identified periventricular white matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol. 1995;52:659–664
  175. Hypertension DetectionFollow-up Program Co-operative Group: Blood pressure studies in 14 communities. JAMA. 1977;237:2385
  176. Hughes CP, Berg LDanziger Wl, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572
  177. Ruitenberg A, van Sweiten JC, Wittemen JCM, et al. Alcohol consumption and risk of demential: the Rotterdam Study. Lancet. 2002;259:281-58
  178. Black S, Roman GC, Geldmacher DS, et al. Donepezil 307 Vascular Dementia Study Group Efficacy and tolerability of doneprezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trail. Stroke. 2003;34:2323–2330

PII: S0011-5029(09)00155-2

doi: 10.1016/j.disamonth.2009.12.007

Disease-A-Month
Volume 56, Issue 3 , Pages 106-147 , March 2010

Article Tools